Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
ConclusionsAll three patients improved clinically and survived.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Actemra | Azithromycin | Coronavirus | COVID-19 | General Medicine | Hydroxychloroquine | Intensive Care | Pandemics | Pathology | Respiratory Medicine | SARS | Zithromax